Rebecca E. Chandler

1.4k total citations
34 papers, 767 citations indexed

About

Rebecca E. Chandler is a scholar working on Infectious Diseases, Toxicology and Health. According to data from OpenAlex, Rebecca E. Chandler has authored 34 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 16 papers in Toxicology and 8 papers in Health. Recurrent topics in Rebecca E. Chandler's work include Pharmacovigilance and Adverse Drug Reactions (16 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Vaccine Coverage and Hesitancy (8 papers). Rebecca E. Chandler is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (16 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Vaccine Coverage and Hesitancy (8 papers). Rebecca E. Chandler collaborates with scholars based in Sweden, United States and United Kingdom. Rebecca E. Chandler's co-authors include G. Niklas Norén, H. Taavola, Karina A. Top, Ola Caster, Kristina Juhlin, I. Ralph Edwards, Nicholas Wood, Lorena Tapia, Rika Wakao and Flor M. Muñoz and has published in prestigious journals such as Nature reviews. Immunology, BMJ and Vaccine.

In The Last Decade

Rebecca E. Chandler

30 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca E. Chandler Sweden 14 320 200 128 112 106 34 767
Srikrishna V Malayala United States 15 430 1.3× 143 0.7× 27 0.2× 83 0.7× 39 0.4× 37 925
David Goodman‐Meza United States 19 375 1.2× 58 0.3× 120 0.9× 164 1.5× 497 4.7× 65 1.3k
Caitlin Dodd Netherlands 14 160 0.5× 73 0.4× 42 0.3× 89 0.8× 421 4.0× 36 903
Gowtham Rao United States 11 124 0.4× 65 0.3× 23 0.2× 33 0.3× 112 1.1× 25 455
Sandeep B Bavdekar India 17 77 0.2× 78 0.4× 40 0.3× 85 0.8× 126 1.2× 72 879
Martina Patone United Kingdom 12 835 2.6× 312 1.6× 17 0.1× 27 0.2× 127 1.2× 24 1.3k
Tiffany Wong Canada 16 100 0.3× 122 0.6× 33 0.3× 84 0.8× 120 1.1× 46 806
Risha Patidar Nigeria 5 600 1.9× 33 0.2× 14 0.1× 66 0.6× 95 0.9× 10 1.1k
Lisa J. McQuay United States 15 336 1.1× 135 0.7× 28 0.2× 41 0.4× 214 2.0× 27 1.1k
Yatir Ben‐Shlomo Israel 6 677 2.1× 194 1.0× 10 0.1× 30 0.3× 131 1.2× 9 1.1k

Countries citing papers authored by Rebecca E. Chandler

Since Specialization
Citations

This map shows the geographic impact of Rebecca E. Chandler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca E. Chandler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca E. Chandler more than expected).

Fields of papers citing papers by Rebecca E. Chandler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca E. Chandler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca E. Chandler. The network helps show where Rebecca E. Chandler may publish in the future.

Co-authorship network of co-authors of Rebecca E. Chandler

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca E. Chandler. A scholar is included among the top collaborators of Rebecca E. Chandler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca E. Chandler. Rebecca E. Chandler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Stergachis, Andy, Esperança Sevene, Rebecca E. Chandler, et al.. (2025). Systematic Review of Active Safety Surveillance of Vaccines and Medicines in Low- and Middle-Income Countries. Drug Safety. 49(4). 405–417.
3.
4.
Agampodi, Suneth, et al.. (2024). Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution. Expert Review of Vaccines. 23(1). 761–772. 4 indexed citations
5.
Black, Steven, Rebecca E. Chandler, Kathryn M. Edwards, & Miriam Sturkenboom. (2023). Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future. Vaccine. 41(25). 3790–3795. 9 indexed citations
6.
Levitan, Bennett, Stephen C. Hadler, William Hurst, et al.. (2023). The Brighton collaboration standardized module for vaccine benefit-risk assessment. Vaccine. 42(4). 972–986. 5 indexed citations
7.
Kochhar, Sonali, Héctor S. Izurieta, Rebecca E. Chandler, et al.. (2023). Benefit-risk assessment of vaccines. Vaccine. 42(4). 969–971. 4 indexed citations
8.
Anjum, Rani Lill, Rebecca E. Chandler, & Elena Rocca. (2022). Dispositions and Causality Assessment in Pharmacovigilance: Proposing the Dx3 Approach for Assessing Causality with Small Data Sets. Pharmaceutical Medicine. 36(3). 153–161. 4 indexed citations
9.
Ekhart, Corine, Florence van Hunsel, Eugène van Puijenbroek, et al.. (2022). Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports. Drug Safety. 45(2). 145–153. 12 indexed citations
10.
Wakao, Rika, Ingrid Lönnstedt, Yasunori Aoki, & Rebecca E. Chandler. (2021). The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan. Drug Safety. 44(6). 681–697. 6 indexed citations
11.
Vogel, Tiphanie P., Karina A. Top, Christos Karatzios, et al.. (2021). Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 39(22). 3037–3049. 132 indexed citations
12.
Jørgensen, Karsten Juhl, et al.. (2020). Suspicions of possible vaccine harms must be scrutinised openly and independently to ensure confidence. npj Vaccines. 5(1). 55–55.
13.
14.
Chandler, Rebecca E., et al.. (2020). Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting. Drug Safety. 43(11). 1121–1131. 23 indexed citations
15.
Baral, Stefan, Rebecca E. Chandler, Ruth Prieto, et al.. (2020). Leveraging epidemiological principles to evaluate Sweden’s COVID-19 response. Annals of Epidemiology. 54. 21–26. 44 indexed citations
16.
17.
Chandler, Rebecca E.. (2019). Modernising vaccine surveillance systems to improve detection of rare or poorly defined adverse events. BMJ. 365. l2268–l2268. 13 indexed citations
18.
Woerner, Andreas, Christoph Rudin, Caterina Bonetto, et al.. (2016). IgA vasculitis (Henoch–Schönlein): Case definition andguidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 35(11). 1559–1566. 8 indexed citations
19.
Chandler, Rebecca E., Katrina Hedberg, & Paul R. Cieslak. (2007). Clostridium difficile-Associated Disease in Oregon: Increasing Incidence and Hospital-Level Risk Factors. Infection Control and Hospital Epidemiology. 28(2). 116–122. 26 indexed citations
20.
Chandler, Rebecca E., Lore E. Lee, John M. Townes, & Randy Taplitz. (2006). Transmission of Group A Streptococcus Limited to Healthcare Workers with Exposure in the Operating Room. Infection Control and Hospital Epidemiology. 27(11). 1159–1163. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Srikrishna V Malayala Breakdown of academic impact, for papers by David Goodman‐Meza Breakdown of academic impact, for papers by Caitlin Dodd Breakdown of academic impact, for papers by Gowtham Rao Breakdown of academic impact, for papers by Sandeep B Bavdekar Breakdown of academic impact, for papers by Martina Patone Breakdown of academic impact, for papers by Tiffany Wong Breakdown of academic impact, for papers by Risha Patidar Breakdown of academic impact, for papers by Lisa J. McQuay Breakdown of academic impact, for papers by Yatir Ben‐Shlomo
Rankless by CCL
2026